{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:14:02Z","timestamp":1791335642741,"version":"4.3.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"crossref","award":["201940306"],"award-info":[{"award-number":["201940306"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270064"],"award-info":[{"award-number":["82270064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cincal Research Youth Project of Shanghai Health Commission","award":["20204Y0383"],"award-info":[{"award-number":["20204Y0383"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03816-9","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T16:46:56Z","timestamp":1750783616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel mesothelioma molecular classification based on malignant cell differentiation"],"prefix":"10.1186","volume":"25","author":[{"given":"Jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingnan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghao","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"issue":"5\u20136","key":"3816_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/10937404.2016.1195323","volume":"19","author":"RA Lemen","year":"2016","unstructured":"Lemen RA. Mesothelioma from asbestos exposures: epidemiologic patterns and impact in the United States. J Toxicol Environ Health B Crit Rev. 2016;19(5\u20136):250\u201365.","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"9483","key":"3816_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet. 2005;366(9483):397\u2013408.","journal-title":"Lancet"},{"key":"3816_CR3","unstructured":"UK CR. Mesothelioma Incidence Statistics; 2022. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/mesothelioma\/incidence#heading-Three."},{"issue":"6","key":"3816_CR4","doi-asserted-by":"publisher","first-page":"1900953","DOI":"10.1183\/13993003.00953-2019","volume":"55","author":"A Scherpereel","year":"2020","unstructured":"Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, et al. ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J. 2020;55(6):1900953.","journal-title":"Eur Respir J"},{"issue":"8","key":"3816_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.15585\/mmwr.mm6608a3","volume":"66","author":"JM Mazurek","year":"2017","unstructured":"Mazurek JM, Syamlal G, Wood JM, Hendricks SA, Weston A. Malignant mesothelioma mortality\u2014United States, 1999\u20132015. MMWR Morb Mortal Wkly Rep. 2017;66(8):214\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"3816_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","volume":"11","author":"F Galateau-Salle","year":"2016","unstructured":"Galateau-Salle F, Churg A, Roggli V, Travis WD, World Health Organization Committee for Tumors of the P. The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification. J Thorac Oncol. 2016;11(2):142\u201354.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"3816_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","volume":"88","author":"P Beckett","year":"2015","unstructured":"Beckett P, Edwards J, Fennell D, Hubbard R, Woolhouse I, Peake MD. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer. 2015;88(3):344\u20138.","journal-title":"Lung Cancer"},{"issue":"11","key":"3816_CR8","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","volume":"7","author":"VW Rusch","year":"2012","unstructured":"Rusch VW, Giroux D, Kennedy C, Ruffini E, Cangir AK, Rice D, et al. Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol. 2012;7(11):1631\u20139.","journal-title":"J Thorac Oncol"},{"issue":"14","key":"3816_CR9","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21(14):2636\u201344.","journal-title":"J Clin Oncol"},{"key":"3816_CR10","unstructured":"(FDA) UFaDA. FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma; 2020. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-nivolumab-and-ipilimumab-unresectable-malignant-pleural-mesothelioma."},{"issue":"10272","key":"3816_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","volume":"397","author":"P Baas","year":"2021","unstructured":"Baas P, Scherpereel A, Nowak AK, Fujimoto N, Peters S, Tsao AS, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2021;397(10272):375\u201386.","journal-title":"Lancet"},{"issue":"4","key":"3816_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","volume":"10","author":"M Nasu","year":"2015","unstructured":"Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, et al. High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol. 2015;10(4):565\u201376.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"3816_CR13","first-page":"2108","volume":"9","author":"PB Illei","year":"2003","unstructured":"Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res. 2003;9(6):2108\u201313.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3816_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno R, Stawiski EW, Goldstein LD, Durinck S, De Rienzo A, Modrusan Z, et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 2016;48(4):407\u201316.","journal-title":"Nat Genet"},{"key":"3816_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100968","volume":"85","author":"T Strub","year":"2021","unstructured":"Strub T, Martel A, Nahon-Esteve S, Baillif S, Ballotti R, Bertolotto C. Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology. Prog Retin Eye Res. 2021;85: 100968.","journal-title":"Prog Retin Eye Res"},{"key":"3816_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.898925","volume":"13","author":"G Gao","year":"2022","unstructured":"Gao G, Deng A, Liang S, Liu S, Fu X, Zhao X, et al. Integration of bulk RNA sequencing and single-cell rna sequencing to reveal uveal melanoma tumor heterogeneity and cells related to survival. Front Immunol. 2022;13: 898925.","journal-title":"Front Immunol"},{"issue":"8","key":"3816_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1158\/2326-6066.CIR-22-0017","volume":"10","author":"EH Knelson","year":"2022","unstructured":"Knelson EH, Ivanova EV, Tarannum M, Campisi M, Lizotte PH, Booker MA, et al. Activation of tumor-cell STING primes NK-cell therapy. Cancer Immunol Res. 2022;10(8):947\u201361.","journal-title":"Cancer Immunol Res"},{"issue":"Database issue","key":"3816_CR18","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res. 2013;41(Database issue):D991\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"3816_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/annonc\/mdu127","volume":"25","author":"MB Suraokar","year":"2014","unstructured":"Suraokar MB, Nunez MI, Diao L, Chow CW, Kim D, Behrens C, et al. Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications. Ann Oncol. 2014;25(6):1184\u201392.","journal-title":"Ann Oncol"},{"issue":"2","key":"3816_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.100938","volume":"4","author":"NU Nair","year":"2023","unstructured":"Nair NU, Jiang Q, Wei JS, Misra VA, Morrow B, Kesserwan C, et al. Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma. Cell Rep Med. 2023;4(2): 100938.","journal-title":"Cell Rep Med"},{"issue":"5","key":"3816_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320.","journal-title":"Nat Biotechnol"},{"key":"3816_CR22","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang R, Zhang S, Song S, Jiang C, Han G, et al. iTALK: an R Package to Characterize and Illustrate Intercellular Communication. BioRvix; 2019.","DOI":"10.1101\/507871"},{"issue":"10","key":"3816_CR23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979\u201382.","journal-title":"Nat Methods"},{"issue":"12","key":"3816_CR24","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"11","key":"3816_CR25","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"issue":"7269","key":"3816_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462(7269):108\u201312.","journal-title":"Nature"},{"issue":"7","key":"3816_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3816_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"issue":"5","key":"3816_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"9","key":"3816_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9(9): e107468.","journal-title":"PLoS ONE"},{"issue":"17","key":"3816_CR31","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.3390\/ijms21176342","volume":"21","author":"E Cakiroglu","year":"2020","unstructured":"Cakiroglu E, Senturk S. Genomics and functional genomics of malignant pleural mesothelioma. Int J Mol Sci. 2020;21(17):6342.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3816_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.celrep.2013.07.009","volume":"4","author":"A Ettahar","year":"2013","unstructured":"Ettahar A, Ferrigno O, Zhang MZ, Ohnishi M, Ferrand N, Prunier C, et al. Identification of PHRF1 as a tumor suppressor that promotes the TGF-beta cytostatic program through selective release of TGIF-driven PML inactivation. Cell Rep. 2013;4(3):530\u201341.","journal-title":"Cell Rep"},{"issue":"6","key":"3816_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.celrep.2015.01.024","volume":"10","author":"C Prunier","year":"2015","unstructured":"Prunier C, Zhang MZ, Kumar S, Levy L, Ferrigno O, Tzivion G, et al. Disruption of the PHRF1 tumor suppressor network by PML-RARalpha drives acute promyelocytic leukemia pathogenesis. Cell Rep. 2015;10(6):883\u201390.","journal-title":"Cell Rep"},{"key":"3816_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-immunol-101320-011235","volume":"40","author":"K Nozaki","year":"2022","unstructured":"Nozaki K, Li L, Miao EA. Innate sensors trigger regulated cell death to combat intracellular infection. Annu Rev Immunol. 2022;40:469\u201398.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"3816_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13046-019-1043-0","volume":"38","author":"R Wei","year":"2019","unstructured":"Wei R, Xiao Y, Song Y, Yuan H, Luo J, Xu W. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis. J Exp Clin Cancer Res. 2019;38(1):112.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"3816_CR36","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1158\/2159-8290.CD-21-0211","volume":"11","author":"R Riscal","year":"2021","unstructured":"Riscal R, Bull CJ, Mesaros C, Finan JM, Carens M, Ho ES, et al. Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma. Cancer Discov. 2021;11(12):3106\u201325.","journal-title":"Cancer Discov"},{"issue":"24","key":"3816_CR37","doi-asserted-by":"publisher","first-page":"8252","DOI":"10.1074\/jbc.RA120.013694","volume":"295","author":"CA Traughber","year":"2020","unstructured":"Traughber CA, Opoku E, Brubaker G, Major J, Lu H, Lorkowski SW, et al. Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice. J Biol Chem. 2020;295(24):8252\u201361.","journal-title":"J Biol Chem"},{"issue":"5","key":"3816_CR38","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/bcr3483","volume":"15","author":"C Danilo","year":"2013","unstructured":"Danilo C, Gutierrez-Pajares JL, Mainieri MA, Mercier I, Lisanti MP, Frank PG. Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development. Breast Cancer Res. 2013;15(5):R87.","journal-title":"Breast Cancer Res"},{"issue":"19","key":"3816_CR39","doi-asserted-by":"publisher","first-page":"16478","DOI":"10.1074\/jbc.C300085200","volume":"278","author":"T Grewal","year":"2003","unstructured":"Grewal T, de Diego I, Kirchhoff MF, Tebar F, Heeren J, Rinninger F, et al. High density lipoprotein-induced signaling of the MAPK pathway involves scavenger receptor type BI-mediated activation of Ras. J Biol Chem. 2003;278(19):16478\u201381.","journal-title":"J Biol Chem"},{"issue":"9","key":"3816_CR40","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.1074\/jbc.M405009200","volume":"280","author":"IN Baranova","year":"2005","unstructured":"Baranova IN, Vishnyakova TG, Bocharov AV, Kurlander R, Chen Z, Kimelman ML, et al. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1\/2 and p38 mitogen-activated protein kinases. J Biol Chem. 2005;280(9):8031\u201340.","journal-title":"J Biol Chem"},{"key":"3816_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.01.007","volume":"59","author":"M du Plessis","year":"2021","unstructured":"du Plessis M, Davis T, Loos B, Pretorius E, de Villiers WJS, Engelbrecht AM. Molecular regulation of autophagy in a pro-inflammatory tumour microenvironment: New insight into the role of serum amyloid A. Cytokine Growth Factor Rev. 2021;59:71\u201383.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3816_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2014a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"3816_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1158\/1078-0432.CCR-11-3314","volume":"19","author":"AM Mulligan","year":"2013","unstructured":"Mulligan AM, Raitman I, Feeley L, Pinnaduwage D, Nguyen LT, O\u2019Malley FP, et al. Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry. Clin Cancer Res. 2013;19(2):336\u201346.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3816_CR44","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1148\/rg.346130089","volume":"34","author":"LT Nickell Jr","year":"2014","unstructured":"Nickell LT Jr, Lichtenberger JP 3rd, Khorashadi L, Abbott GF, Carter BW. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Radiographics. 2014;34(6):1692\u2013706.","journal-title":"Radiographics"},{"issue":"Suppl 1","key":"3816_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41379-021-00895-7","volume":"35","author":"S Dacic","year":"2022","unstructured":"Dacic S. Pleural mesothelioma classification-update and challenges. Mod Pathol. 2022;35(Suppl 1):51\u20136.","journal-title":"Mod Pathol"},{"issue":"5","key":"3816_CR46","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jtho.2021.12.014","volume":"17","author":"JL Sauter","year":"2022","unstructured":"Sauter JL, Dacic S, Galateau-Salle F, Attanoos RL, Butnor KJ, Churg A, et al. The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification. J Thorac Oncol. 2022;17(5):608\u201322.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"3816_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2004086","volume":"15","author":"AE Shaw","year":"2017","unstructured":"Shaw AE, Hughes J, Gu Q, Behdenna A, Singer JB, Dennis T, et al. Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses. PLoS Biol. 2017;15(12): e2004086.","journal-title":"PLoS Biol"},{"issue":"5","key":"3816_CR48","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.chom.2020.09.014","volume":"28","author":"IN Boys","year":"2020","unstructured":"Boys IN, Xu E, Mar KB, De La Cruz-Rivera PC, Eitson JL, Moon B, et al. RTP4 is a potent IFN-inducible anti-flavivirus effector engaged in a host-virus arms race in bats and other mammals. Cell Host Microbe. 2020;28(5):712-23 e9.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"3816_CR49","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.cell.2018.09.022","volume":"175","author":"A Wroblewska","year":"2018","unstructured":"Wroblewska A, Dhainaut M, Ben-Zvi B, Rose SA, Park ES, Amir ED, et al. Protein barcodes enable high-dimensional single-cell CRISPR screens. Cell. 2018;175(4):1141\u201355.","journal-title":"Cell"},{"issue":"1","key":"3816_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s41065-021-00183-z","volume":"158","author":"Y Li","year":"2021","unstructured":"Li Y, Qi J, Yang J. RTP4 is a novel prognosis-related hub gene in cutaneous melanoma. Hereditas. 2021;158(1):22.","journal-title":"Hereditas"},{"issue":"4","key":"3816_CR51","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41423-019-0245-x","volume":"17","author":"MP Pistillo","year":"2020","unstructured":"Pistillo MP, Carosio R, Banelli B, Morabito A, Mastracci L, Ferro P, et al. IFN-gamma upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1\/PD-L1 blockade. Cell Mol Immunol. 2020;17(4):410\u20131.","journal-title":"Cell Mol Immunol"},{"issue":"32","key":"3816_CR52","doi-asserted-by":"publisher","first-page":"19465","DOI":"10.1073\/pnas.2006492117","volume":"117","author":"X He","year":"2020","unstructured":"He X, Ashbrook AW, Du Y, Wu J, Hoffmann HH, Zhang C, et al. RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology. Proc Natl Acad Sci U S A. 2020;117(32):19465\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3816_CR53","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/sj.cdd.4402194","volume":"14","author":"T Fernandes-Alnemri","year":"2007","unstructured":"Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, Jankowski W, et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 2007;14(9):1590\u2013604.","journal-title":"Cell Death Differ"},{"issue":"7575","key":"3816_CR54","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660\u20135.","journal-title":"Nature"},{"issue":"7799","key":"3816_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-020-2079-1","volume":"579","author":"Q Wang","year":"2020","unstructured":"Wang Q, Wang Y, Ding J, Wang C, Zhou X, Gao W, et al. A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature. 2020;579(7799):421\u20136.","journal-title":"Nature"},{"issue":"1","key":"3816_CR56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7(1):196.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"3816_CR57","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1084\/jem.20181218","volume":"216","author":"PH Lee","year":"2019","unstructured":"Lee PH, Yamamoto TN, Gurusamy D, Sukumar M, Yu Z, Hu-Li J, et al. Host conditioning with IL-1beta improves the antitumor function of adoptively transferred T cells. J Exp Med. 2019;216(11):2619\u201334.","journal-title":"J Exp Med"},{"issue":"6","key":"3816_CR58","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1158\/1541-7786.MCR-18-0910","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui J, Zhou Z, Yang H, Jiao F, Li N, Gao Y, et al. MST1 suppresses pancreatic cancer progression via ROS-induced pyroptosis. Mol Cancer Res. 2019;17(6):1316\u201325.","journal-title":"Mol Cancer Res"},{"issue":"9255","key":"3816_CR59","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539\u201345.","journal-title":"Lancet"},{"issue":"7","key":"3816_CR60","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5483\/BMBRep.2015.48.7.036","volume":"48","author":"Y Mi","year":"2015","unstructured":"Mi Y, Zhang C, Bu Y, Zhang Y, He L, Li H, et al. DEPDC1 is a novel cell cycle related gene that regulates mitotic progression. BMB Rep. 2015;48(7):413\u20138.","journal-title":"BMB Rep"},{"issue":"1","key":"3816_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188467","volume":"1875","author":"CA Raab","year":"2021","unstructured":"Raab CA, Raab M, Becker S, Strebhardt K. Non-mitotic functions of polo-like kinases in cancer cells. Biochim Biophys Acta Rev Cancer. 2021;1875(1): 188467.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3816_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pharmthera.2015.04.002","volume":"151","author":"L Wang","year":"2015","unstructured":"Wang L, Zhang J, Wan L, Zhou X, Wang Z, Wei W. Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacol Ther. 2015;151:141\u201351.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"3816_CR63","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1158\/0008-5472.CAN-17-1924","volume":"78","author":"AM Horning","year":"2018","unstructured":"Horning AM, Wang Y, Lin CK, Louie AD, Jadhav RR, Hung CN, et al. Single-cell RNA-seq reveals a subpopulation of prostate cancer cells with enhanced cell-cycle-related transcription and attenuated androgen response. Cancer Res. 2018;78(4):853\u201364.","journal-title":"Cancer Res"},{"issue":"9","key":"3816_CR64","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41419-022-05222-9","volume":"13","author":"M Chen","year":"2022","unstructured":"Chen M, Zhao Z, Wu L, Huang J, Yu P, Qian J, et al. E2F1\/CKS2\/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma. Cell Death Dis. 2022;13(9):784.","journal-title":"Cell Death Dis"},{"issue":"12","key":"3816_CR65","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1158\/0008-5472.CAN-07-6345","volume":"68","author":"H Peinado","year":"2008","unstructured":"Peinado H, Moreno-Bueno G, Hardisson D, Perez-Gomez E, Santos V, Mendiola M, et al. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas. Cancer Res. 2008;68(12):4541\u201350.","journal-title":"Cancer Res"},{"issue":"9","key":"3816_CR66","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/emmm.201100156","volume":"3","author":"G Moreno-Bueno","year":"2011","unstructured":"Moreno-Bueno G, Salvador F, Martin A, Floristan A, Cuevas EP, Santos V, et al. Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas. EMBO Mol Med. 2011;3(9):528\u201344.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"3816_CR67","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/hep.27320","volume":"60","author":"CC Wong","year":"2014","unstructured":"Wong CC, Tse AP, Huang YP, Zhu YT, Chiu DK, Lai RK, et al. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Hepatology. 2014;60(5):1645\u201358.","journal-title":"Hepatology"},{"issue":"2","key":"3816_CR68","first-page":"932","volume":"40","author":"X Cui","year":"2018","unstructured":"Cui X, Wang G, Shen W, Huang Z, He H, Cui L. Lysyl oxidase-like 2 is highly expressed in colorectal cancer cells and promotes the development of colorectal cancer. Oncol Rep. 2018;40(2):932\u201342.","journal-title":"Oncol Rep"},{"issue":"19","key":"3816_CR69","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1038\/sj.emboj.7600781","volume":"24","author":"H Peinado","year":"2005","unstructured":"Peinado H, Del Carmen Iglesias-de la Cruz M, Olmeda D, Csiszar K, Fong KS, Vega S, et al. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J. 2005;24(19):3446\u201358.","journal-title":"EMBO J"},{"issue":"2","key":"3816_CR70","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/35000034","volume":"2","author":"E Batlle","year":"2000","unstructured":"Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2(2):84\u20139.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"3816_CR71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"A Cano","year":"2000","unstructured":"Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2(2):76\u201383.","journal-title":"Nat Cell Biol"},{"issue":"19","key":"3816_CR72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102050118","volume":"118","author":"AP Deshmukh","year":"2021","unstructured":"Deshmukh AP, Vasaikar SV, Tomczak K, Tripathi S, den Hollander P, Arslan E, et al. Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing. Proc Natl Acad Sci U S A. 2021;118(19): e2102050118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3816_CR73","doi-asserted-by":"crossref","unstructured":"Turini S, Bergandi L, Gazzano E, Prato M, Aldieri E. Epithelial to mesenchymal transition in human mesothelial cells exposed to asbestos fibers: role of TGF-beta as mediator of malignant mesothelioma development or metastasis via EMT event. Int J Mol Sci. 2019;20(1):150.","DOI":"10.3390\/ijms20010150"},{"key":"3816_CR74","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31756","volume":"7","author":"A Ramachandran","year":"2018","unstructured":"Ramachandran A, Vizan P, Das D, Chakravarty P, Vogt J, Rogers KW, et al. TGF-beta uses a novel mode of receptor activation to phosphorylate SMAD1\/5 and induce epithelial-to-mesenchymal transition. Elife. 2018;7: e31756.","journal-title":"Elife"},{"issue":"25","key":"3816_CR75","doi-asserted-by":"publisher","first-page":"eaat1482","DOI":"10.1126\/sciimmunol.aat1482","volume":"3","author":"AK Abbas","year":"2018","unstructured":"Abbas AK, Trotta E, Simeonov DR, Marson A, Bluestone JA. Revisiting IL-2: biology and therapeutic prospects. Sci Immunol. 2018;3(25):eaat1482.","journal-title":"Sci Immunol"},{"issue":"3","key":"3816_CR76","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou N, Zhou L, Wang J, Zhou Y, Zhang T, et al. IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor. Nat Immunol. 2021;22(3):358\u201369.","journal-title":"Nat Immunol"},{"issue":"9","key":"3816_CR77","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1158\/1535-7163.MCT-21-0943","volume":"21","author":"F Dammeijer","year":"2022","unstructured":"Dammeijer F, van Gulijk M, Klaase L, van Nimwegen M, Bouzid R, Hoogenboom R, et al. Low-dose JAK3 inhibition improves antitumor T-cell immunity and immunotherapy efficacy. Mol Cancer Ther. 2022;21(9):1393\u2013405.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3816_CR78","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13058-018-0946-6","volume":"20","author":"R El Ansari","year":"2018","unstructured":"El Ansari R, Craze ML, Miligy I, Diez-Rodriguez M, Nolan CC, Ellis IO, et al. The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours. Breast Cancer Res. 2018;20(1):21.","journal-title":"Breast Cancer Res"},{"issue":"7","key":"3816_CR79","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1365-2559.2009.03300.x","volume":"54","author":"H Imai","year":"2009","unstructured":"Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, et al. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology. 2009;54(7):804\u201313.","journal-title":"Histopathology"},{"issue":"1","key":"3816_CR80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41588-020-00753-3","volume":"53","author":"AK Najumudeen","year":"2021","unstructured":"Najumudeen AK, Ceteci F, Fey SK, Hamm G, Steven RT, Hall H, et al. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nat Genet. 2021;53(1):16\u201326.","journal-title":"Nat Genet"},{"issue":"1","key":"3816_CR81","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/hep.28223","volume":"63","author":"YY Park","year":"2016","unstructured":"Park YY, Sohn BH, Johnson RL, Kang MH, Kim SB, Shim JJ, et al. Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Hepatology. 2016;63(1):159\u201372.","journal-title":"Hepatology"},{"issue":"14","key":"3816_CR82","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/onc.2010.566","volume":"30","author":"MM Chaturvedi","year":"2011","unstructured":"Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB. NF-kappaB addiction and its role in cancer: \u2018one size does not fit all.\u2019 Oncogene. 2011;30(14):1615\u201330.","journal-title":"Oncogene"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03816-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T18:02:44Z","timestamp":1750788164000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03816-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3816"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03816-9","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"17 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Shanghai Pulmonary Hospital affiliated to Tongji University. All experiments were performed in accordance with relevant guidelines and regulations. Informed consent was obtained from all subjects and their legal guardians involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}